Referring New Patients  |   Organizations  |   Search  |   Contact Us  
  Home  |  The Practice  |  Referral  |  Disorders  |  Treatment   Discussion Group  |


Question of the Week

The Psychological Letter

Case Management Update
The Practice

Clinical Services

Educational Services

The Seminar Series

Ask Dr. Adams

Curriculum Vitae

 Making OnLine Referral

Clinical Services / Educational Services / Organizations / E-Mail  

Atlanta Medical Psychology
The clinical practice of Dr. David B. Adams is located in The Medical Quarters in the northside of Atlanta at the junction of Scottish Rite, Northside and Saint Joseph's Hospitals. Dr. Adams consults to occupational medicine, surgeons, nurse case managers, insurers and employers regarding the psychological impact of work-related injury and the role of psychological factors in short- and long-term disability. 

 

PAST QUESTIONS OF THE WEEK

December 19, 2005

Q "Do people that are put on a respirator ever become depressed being on it?"

This may be helpful: "Caregivers of patients who have received prolonged mechanical ventilation may be at risk for depression and poor physical health in the months following hospital discharge.

The 8-week disease management program, to which 211 of the caregivers were randomly assigned, included emotional support from an advanced practice nurse through discussions, referrals, and reassurance, as well as instrumental support through care coordination, education and communication. There were at least eight nurse-initiated contacts in the intervention group.

At the time of patient's discharge from the hospital, 69.2% of caregivers in the control group and 61.7% in the experimental group exhibited mild or no depression, based on Center for Epidemiologic Studies depression scale (CES-D) scores.

Two months later, 61.2% of the experimental group and 53.5% of the control group had no more than mild depression scores (p < 0.05). The experimental group also had a larger percentage of caregivers who improved or stayed the same (55.6% versus 40.8%).

Thus, the investigators note, "the intervention was, at the 2-month point, managing to keep some caregivers from progressing to moderate or severe depression."

"The clinical significance of the intervention," they add, "may be that empathetic listening, support in planning and decision making, and referrals for support may have been instrumental in minimizing depression in some caregivers.

The authors also observed that 2-month CES-D scores were significantly higher among caregivers of patients residing in an institution (15.5 versus 9.63, p = 0.00001). There were also significantly worse outcomes for disrupted schedule, lack of family support and health problems among those with institutionalized patients.

Dr. Douglas's team posits that "some possible sources of their risk for depression could be the more debilitated nature of institutionalized patients, possible guilt because the patient is not being cared for at home, and possible frustration by caregivers who have less control over their loved one's care in an institutional setting." Chest 2005;128:3925-3936.

December 12, 2005

Q "How much does stress play a role in diabetes?"

A "Intensive, home-based psychotherapy can significantly reduce diabetes-related stress in adolescents with type 1 diabetes...there are empirically-supported treatments that have been shown to make a difference in improving both psychosocial well-being, adherence, and health outcomes for seriously non-adherent youth."

Researchers...investigated whether intensive, multisystemic psychotherapy (MST) targeting family and other barriers to good adherence would affect the adolescent's stress related to diabetes and whether this would influence adherence and metabolic control.

Adolescents who received MST experienced significantly reduced levels of stress compared with those in the control group... The intervention appeared equally effective for younger and older, male and female, black and other adolescents.

Diabetes stress was related significantly to metabolic control both at baseline and after treatment, the results indicate, but there was no association with age or ethnicity.

Structural equation modeling indicated that the MST intervention directly affected diabetic stress and adherence, but there was no support for a specific effect of stress on adherence."

Pediatrics 2005;116:e826-e832.

December 5, 2005

Q "My wife has major depression, and I was wondering if they know any more about why this happens in the brain."

A  "Results of a functional MRI study demonstrate that several areas of the brain associated with reward processing respond differently to stimulation in patients with major depressive disorder (MDD).

Therefore, "the brain reward system may be an excellent target for novel treatment approaches in drug development research...The authors define the brain reward system as "a neurobiological system that consists of extensive neural pathways that mediate reward behaviors such as pleasure and motivation." They theorize that this system "may represent a key neuroanatomical substrate of anhedonia, a core symptom of depression."

The investigators observed that, based on a standardized test (the Addiction Research Center Inventory, ARCI), MDD subjects had a hypersensitive, 2-fold increased response to the rewarding effects of the drug (dextroamphetamine). There was a positive correlation between ARCI scores and measures of anhedonia.

MDD subjects exhibited significantly decreased activation following dextroamphetamine administration in dopamine-rich regions of the brain. Specifically, these involved the right ventrolateral prefrontal cortex, the left and right caudate and putamen, the left orbitofrontal cortex, and the supplementary motor cortex and premotor cortex. Increased activation was observed in the left and right temporal pole.

"Results of this study provide support for the involvement of dopaminergic mechanisms in the altered reward processing in MDD," Dr. Busto's group maintains.

Arch Gen Psychiatry 2005;62:1228-1236"

November 28, 2005

Q "Any research on what makes a psychopath?"

A "A variant in the catechol O-methyltransferase (COMT) gene and birth weight are predictive of early-onset antisocial behavior in children with attention-deficit/hyperactivity disorder.

The researchers conducted a family-based genetic study from 1997 to 2003. Included were 240 children recruited from child and adolescent psychiatric and child health clinics who met the diagnostic criteria for attention-deficit/hyperactivity disorder or hyperkinetic disorder.

Specifically, mean conduct disorder scores were higher in those with the val/val genotype and those with birthweight lower than 2500 g. The association was independent of the effects of age, sex, verbal IQ, and performance IQ.

The results of this study have potentially important implications insofar as they suggest that among those with ADHD who are at high risk of early-onset antisocial behavior, possession of a specific risk genotype, the COMT gene variant val/val genotype, not only predicts antisocial behavior in itself but also increases susceptibility to the effects of prenatal risk as indexed by birth weight.

Arch Gen Psychiatry 2005;62:1275-1278.

November 21, 2005

Q "I have been on Zoloft for two years, and I read that this may cause me to get breast cancer. Is that definitely true?"

A "It was reported that clinically relevant doses of [fluoxetine] accelerated the growth of mammary tumors in rodents.Contrary to findings in rodent studies, the use of selective serotonin reuptake inhibitors (SSRIs) does not appear to increase the risk of breast cancer. Physicians can feel confident that the evidence has accumulated that use of SSRIs for 4 to 5 years does not increase the risk of breast cancer.

Regular use of SSRIs was not associated with breast cancer risk after adjustment for other risk factors, with an odds ratio of 1.1, which wasn't significant, the investigators report.

The odds ratios were not significantly different for women who recently used SSRIs and for women who had stopped taking SSRIs at least a year prior to their interview. Moreover, all odds ratios were similar for pre- and post-menopausal women, the results indicate.

These findings provide assurance that use of SSRIs for durations of 4-5 years does not increase the risk of breast cancer. However, these results do not address the risk of taking these drugs continually for decades."

Am J Epidemiol 2005;182:835-838.

November 14, 2005

Q "My sister's son has cancer. It is very tragic, and she seems to be having a particularly rough time with it naturally...anything special which we should look for?"

A You may find this helpful: "Most parents of children undergoing cancer treatment report posttraumatic stress disorder (PTSD) symptoms...Symptoms of PTSD have been reported in parents of children who have completed treatment for cancer...More than two thirds of the mothers and 57% of the fathers had PTSD within the moderate-to-severe range, the results indicate. In families in which both parents participated in the survey, 79.2% had at least one parent with moderate-to-severe PTSD.

Only rarely did both parents report severe symptoms, and it was uncommon for both parents to report mild PTSD.

Treatment intensity was not associated with distress level for mothers or fathers, the researchers note, but there was a low-magnitude negative association between the length of time since their child's diagnosis and the level of PTSD...(the symptoms may be) part of the process of responding and reacting to one's circumstances and may be adaptive in certain ways."

Knowledge and attention to PTSD symptoms can lead to more appropriate multidisciplinary care of the patient and family.

Early identification of at-risk families may promote the development and evaluation of effective brief treatments. By helping caregivers address their own psychological well-being, we may be best assuring that the psychological needs of the patients are also met.

Brief and efficacious treatments have been developed to assist parents in adjusting to their child's diagnosis and treatment, and effective psychological treatments for posttraumatic disorders have been developed.."

J Clin Oncol 2005;23:7405-7410,7375-7377.

November 7, 2005

Q "I want to quit smoking but know that the patch contains nicotine which causes cancer...therefore, I do not know how to quit..."

A "Quoting a recent study "Many smokers think that nicotine causes cancer, and that fear can significantly interfere with efforts to stop...the majority of smokers - 71.9% of women and 59.4% of men - believed that nicotine causes cancer. In addition, 75% of women and 64.5% of men expressed worry that smoking would give them cancer, and 71.9% of women and 63.1% of men smoked "light" cigarettes, thinking this would lower intake of nicotine and thus lower their risk of cancer.

...Nicotine does not cause cancer, but that is why patients are reluctant to use patches to help them quit...It's the delivery system that carries the risk...It's the cigarette smoke that contains carcinogens, neurotoxins and other toxins.

More women expressed fear, guilt and worry about the risks they were taking with smoking (77.2% versus 61.7% of men). They were also more afraid of failure in their attempts to quit than men (17.5% versus 10.7%). However, quit rates at 30 days were essentially the same for women and men (59.1% versus 54.9%).

Nicotine is the drug that smokers crave. That's why the patches are a good alternative for those who want to quit...Smokers need a comprehensive care program that includes pharmacotherapy using nicotine patches...
Complete abstinence is not used, because going "cold turkey" has a very high failure rate...A program that involves behavior modification, guided imagery and support systems are helpful," she concluded, "and patches are a very useful tool in the program."

October 31, 2005

Q "Stress seems to have a big role in health...is there any other interesting research about stress?..."

A  "A short period of stress in early life can lead to impaired learning and memory and a decline in related cognitive abilities, results of animal study indicate...psychological early-life stress in rats causes a deterioration of the hippocampus that progresses from young adulthood to middle age.

The researchers elicited early-life stress in rats by limiting the nesting material in cages where they lived with their mothers. This led to emotional stress (enlarged adrenals, increased corticosterone levels, and modest weight loss) in both mothers and pups. All signs of this stress disappeared by the time the rats reached adulthood...

Starting in middle age, the rats that endured early-life stress began to exhibit deficits in their ability to remember the location of objects they had seen before. They also had trouble recognizing objects that they had encountered on the previous day. These difficulties worsened as the rats grew older, and developed much more rapidly than in rats that were raised from the first week of life in a typical nurturing environment.

...cellular bases for the cognitive difficulties were a result of change in the fine structure of brain cells, which impaired their ability to enhance their communication, as normally happens during the process of learning... facilitated communication is known as long-term potentiation."

...over 50% of the world's children are raised under stressful conditions. While it has been suspected that early life stresses can lead to later cognitive impairment, it is not possible to affirm this suspicion in human studies, because the genetic background of children or other confounders make these analyses too complex...

J Neurosci 2005;25:9328-9338.

October 24, 2005

Q "Can psychological factors effect things like cancer?"

A recent article indicates that: "Ovarian cancer patients with greater social support have stronger natural killer (NK) cell activity in tumor-infiltrating lymphocytes as well as peripheral blood mononuclear cells...a link between psychosocial factors and immune function in cells isolated from human tumors....the researchers compared NK cell cytotoxicity (NKCC) in peripheral blood, TIL and ascites in 42 patients with ovarian cancer. Twenty-three patients with suspected ovarian cancer later found to be benign served as a control group.

In peripheral blood, the researchers found, NKCC was lower in the ovarian cancer patients than in the women with benign masses. Ovarian cancer patients had lower NKCC activity in TIL compared to PBMC and ascites.

However, after adjustment for cancer stage, stronger social support was related to higher NKCC in TIL and PBMC, while higher distress was tied to lower NKCC in TIL. Multivariate analysis found the effects of social support and distress were independent.Psychosocial factors were most strongly tied to NKCC in TIL, which is "noteworthy...the sympathetic nervous system serves as a direct link between the ovary and the central nervous system, while the acidic environment of the ovary may help preserve catecholamines.

The magnitude of relationships between social support, distress and NKCC, particularly in TIL, was quite large and suggests that psychosocial factors may contribute to the robustness of the innate immune response in the tumor microenvironment..."

J Clin Oncol 2005;23:7105-7113.

October 17, 2005

Q "I gather that sometime schizophrenia is not recognized for awhile in some families. Does this result in the person taking longer to get better?"

A  A recent article indicates: "The greater the interval between the onset of psychosis and its treatment, the greater the severity of negative symptoms...On average, there is a delay of over a year -- or longer -- from the time that the symptoms of schizophrenia first emerge to the time that the person first receives treatment...the sooner treatment is started, the better the clinical and functional outcome...A shorter duration of untreated psychosis was associated with greater response to antipsychotic treatment. This was manifested by improvement in severity of global psychopathology in 5 studies, positive symptom severity in 13 studies and negative symptom severity in 14 studies.

Thus, ameliorating the symptoms of the initial psychosis may not only lessen the immediate suffering and burden of disease experienced by patients and their families, but may also improve long-term prognosis by limiting progression of the illness and preserving a person's ability to respond to antipsychotic medication.

Intervention programs that are effective in reducing the length of the initial psychotic episode," she concluded, "may enhance the likelihood of recovery from a first episode of schizophrenia."

Am J Psychiatry 2005;162:1785-1804.

October 10, 2005

Q "Can stress cause a child to become diabetic?"

A  You will may be interested in this: "Mothers' psychological stress, measured as exposure to negative life events, seems to be involved in the onset or progression of diabetes-related beta-cell destruction in young children...mothers' experience of divorce or violence raised the risk of diabetes-related autoimmunity in children at age 2.5 years by roughly threefold....this could be explained by increased cortisol concentrations leading to insulin resistance, which in turn may stress the insulin-producing beta cells and thereby trigger a diabetes-related autoimmune reaction in genetically predisposed children...the associations between psychological stress and autoimmunity were not likely to be explained by any of the known risk factors for type 1 diabetes analyzed: type 1 diabetes in the family or extended family, increased parental age, childhood infections, body weight of the child, delivery by caesarean section, and the need for neonatal intensive care...conclude that psychological stress could be a risk factor for the development of type 1 diabetes, since it appears to be one trigger mechanism behind diabetes-related autoimmunity early in life...it is important to reduce negative stress in children and this issue needs priority especially among clinicians working with children. It is central to look at the whole family situation and to try to reduce parenting stress, by for example discussing various coping strategies in connection with serious life events."

Diabetes Care 2005;28:2394-2399.

October 3, 2005

Q "Our daughter is bulimic and also seems to be having panic attacks. This does not seem logical to us, and we wonder if it is medication she is taking."

A  While medication is always a consideration, please note: "The results of a study support shared transmission of eating disorders and anxiety disorders in adolescent girls.

The investigators observed significant comorbidity between eating disorders and major depression, anxiety disorders, and nicotine dependence.

These results suggest that eating disorders and anxiety disorders share familial risk factors.

The next step would be to examine whether the shared transmission is explained by genetic or environmental factors or a combination of both.

The participants in the study were young (and) it is likely that some of the participants who did not have mood disorders or substance use disorders may develop these problems in the future. As participants move through the period of risk for developing different kinds of mental disorders, we might find evidence of shared transmission between eating disorders and other types of mental disorders.

Int J Eat Disord 2005;38:99-105.

 

 

Send mail to a friend   Contact The Practice

 

© 2005 Atlanta Medical Psychology.